InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the detailed record of transactions filed by Flynn Daniel Lee, Directeur Scientifique. Officer active across 1 companies, notably Deciphera Pharmaceuticals, Inc.. Aggregated, 7 filings have been logged. Total volume traded: €40k. The latest transaction was filed on 16 June 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€18,0211,768 shares@ €10.192645.3% of flow
Common Stock
SEC:0001209191-22-038425:0·
€10,8851,366 shares@ €7.968827.4% of flow
Common Stock
SEC:0001209191-22-011360:0·
€10,8851,366 shares@ €7.9688100.0% of flow
Common Stock
SEC:0001209191-22-011360·
020,500 shares0
Common Stock
SEC:0001209191-22-004074·
020,500 shares0
Common Stock
SEC:0001209191-22-004074:0·
011,100 shares0
Common Stock
SEC:0001209191-21-070227·
011,100 shares0
Common Stock
SEC:0001209191-21-070227:0·
7 of 7 declarations
About Flynn Daniel Lee
Daniel Lee Flynn is Chief Scientific Officer at Deciphera Pharmaceuticals, Inc. He is responsible for leading the company's research and development efforts. His scientific expertise is essential for the development of new treatments and for innovation within Deciphera Pharmaceuticals.
